The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities
Open accessAbstract
Poor medication adherence may increase rates of loss to follow-up, disease relapse and drug resistance for individuals with active tuberculosis (TB). While TB programmes have historically used directly observed therapy (DOT) to address adherence, concerns have been raised about the patient burden, ethical limitations, effectiveness in improving treatment outcomes and long-term feasibility of DOT for health systems. Digital adherence technologies (DATs)—which include feature phone–based and smartphone-based technologies, digital pillboxes and ingestible sensors—may facilitate more patient-centric approaches for monitoring adherence, though available data are limited. Depending on the specific technology, DATs may help to remind patients to take their medications, facilitate digital observation of pill-taking, compile dosing histories and triage patients based on their level of adherence, which can facilitate provision of individualised care by TB programmes to patients with varied levels of risk. Research is needed to understand whether DATs are acceptable to patients and healthcare providers, accurate for measuring adherence, effective in improving treatment outcomes and impactful in improving health system efficiency. In this article, we describe the landscape of DATs that are being used in research or clinical practice by TB programmes and highlight priorities for research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
User Acceptance of Information Technology: Toward A Unified View1
Venkatesh, V., Morris, M. G., Davis, G. B., & Davis, F. D. (2003) · MIS Quarterly · doi:10.2307/30036540 · Cited by 45,035
The Technology Acceptance Model: Its past and its future in health care
Holden, R. J., & Karsh, B.-T. (2010) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2009.07.002 · Cited by 2,669
A new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
Impact of HIV‐related stigma on treatment adherence: systematic review and meta‐synthesis
Katz, I. T., Ryu, A. E., Onuegbu, A. G., Psaros, C., Weiser, S. D., Bangsberg, D. R., & Tsai, A. C. (2013) · Journal of the International AIDS Society · doi:10.7448/ias.16.3.18640 · Cited by 1,126
A Holistic Framework to Improve the Uptake and Impact of eHealth Technologies
van Gemert-Pijnen, J. E., Nijland, N., van Limburg, M., Ossebaard, H. C., Kelders, S. M., Eysenbach, G., & Seydel, E. R. (2011) · Journal of Medical Internet Research · doi:10.2196/jmir.1672 · Cited by 1,126 · cited 1×
“40 41 44 In general, these models evaluate ‘ease of use’ (ie, how easily users are able to learn the DAT), ‘perceived usefulness’ (ie,”
Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research
Munro, S. A., Lewin, S. A., Smith, H. J., Engel, M. E., Fretheim, A., & Volmink, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040238 · Cited by 1,080
Pop-Eleches, C., Thirumurthy, H., Habyarimana, J. P., Zivin, J. G., Goldstein, M. P., de Walque, D., MacKeen, L., Haberer, J., Kimaiyo, S., Sidle, J., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834380c1 · Cited by 982
Self-citationYusof, M. M., Kuljis, J., Papazafeiropoulou, A., & Stergioulas, L. K. (2008) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2007.08.011 · Cited by 740
Directly observed therapy for treating tuberculosis
Karumbi, J., & Garner, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003343.pub4 · Cited by 644
Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data
Wang, L., Zhang, H., Ruan, Y., Chin, D. P., Xia, Y., Cheng, S., Chen, M., Zhao, Y., Jiang, S., Du, X., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62639-2 · Cited by 538
Cited by
Furin, J., Cox, H., & Pai, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30308-3 · Cited by 873
Self-citationManagement of drug-resistant tuberculosis
Lange, C., Dheda, K., Chesov, D., Mandalakas, A. M., Udwadia, Z., & Horsburgh, C. R. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31882-3 · Cited by 299
Vernon, A., Fielding, K., Savic, R., Dodd, L., & Nahid, P. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002884 · Cited by 104
India’s syndemic of tuberculosis and COVID-19
Shrinivasan, R., Rane, S., & Pai, M. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003979 · Cited by 71
Self-citationEthical and legal issues of ingestible electronic sensors
Gerke, S., Minssen, T., Yu, H., & Cohen, I. G. (2019) · Nature Electronics · doi:10.1038/s41928-019-0290-6 · Cited by 56
Metadata
- Authors
- Subbaraman, R., de Mondesert, L., Musiimenta, A., Pai, M., Mayer, K. H., Thomas, B. E., & Haberer, J.
- Venue
- BMJ Global Health
- Publisher
- BMJ
- Published
- 2018-10
- Volume
- 3
- Issue
- 5
- Pages
- e001018
- ISSN
- 2059-7908 (ISSN-L)
- OpenAlex
- W2896055019
- Cited by
- 255
- References
- 82
- FWCI
- 34.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. https://app.cochat.ai/papers/10.1136/bmjgh-2018-001018
- The paper
- Subbaraman, R., de Mondesert, L., Musiimenta, A., Pai, M., Mayer, K. H., Thomas, B. E., & Haberer, J. (2018). Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Global Health. https://doi.org/10.1136/bmjgh-2018-001018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.